Literature DB >> 11736731

Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis.

J Carrier1, E Aghdassi, I Platt, J Cullen, J P Allard.   

Abstract

BACKGROUND: Iron supplementation may increase disease activity in ulcerative colitis, possibly through the production of reactive oxygen species from the Fenton reaction. AIM: To assess the effects of two doses of oral iron on intestinal inflammation and oxidative stress in experimental colitis.
METHODS: Colitis was induced in rats by giving 5% dextran sulphate sodium in drinking water for 7 days. First, using a 2 x 2 factorial design, rats with or without dextran sulphate sodium received the regular diet or a diet containing iron 3%/kg diet. Second, rats with dextran sulphate sodium-induced colitis were supplemented with iron 0.3%/kg diet and compared with rats on dextran sulphate sodium and regular diet. The body weight change, histological scores, colon length, rectal bleeding, plasma and colonic lipid peroxides, colonic glutathione peroxidase and plasma vitamin E and C were measured. Faecal analysis for haem and total, free and ethylenediaminetetra-acetic acid-chelatable iron was also performed.
RESULTS: Iron 3% and iron 0.3% increased the activity of dextran sulphate sodium-induced colitis, as demonstrated by higher histological scores, heavier rectal bleeding and further shortening of the colon. This was associated with increased lipid peroxidation and decreased antioxidant vitamins. Faecal iron available to the Fenton reaction was increased in a dose-dependent manner.
CONCLUSIONS: Iron supplementation taken orally enhanced the activity of dextran sulphate sodium-induced colitis and is associated with an increase in oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11736731     DOI: 10.1046/j.1365-2036.2001.01113.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  54 in total

Review 1.  Diagnosis and management of iron deficiency anemia in patients with IBD.

Authors:  Jürgen Stein; Franz Hartmann; Axel U Dignass
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-05       Impact factor: 46.802

Review 2.  Treatment of iron deficiency anemia associated with gastrointestinal tract diseases.

Authors:  Ulas D Bayraktar; Soley Bayraktar
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

Review 3.  Diet and relapsing ulcerative colitis: take off the meat?

Authors:  H Tilg; A Kaser
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

4.  Fractionation and evaluation of radical-scavenging peptides from in vitro digests of buckwheat protein.

Authors:  Yuanyuan Ma; Youling L Xiong; Jianjun Zhai; Haining Zhu; Thomas Dziubla
Journal:  Food Chem       Date:  2010-02-01       Impact factor: 7.514

Review 5.  Epidemiology and risk factors for IBD.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-03       Impact factor: 46.802

Review 6.  Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide.

Authors:  Fernando Gomollón; Javier P Gisbert
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

7.  The effect of exopolysaccharide-producing probiotic strains on gut oxidative damage in experimental colitis.

Authors:  Neriman Sengül; Sevil Işık; Belma Aslım; Gülberk Uçar; Ali Eba Demirbağ
Journal:  Dig Dis Sci       Date:  2010-08-04       Impact factor: 3.199

8.  Exacerbation of dextran sulfate sodium-induced colitis by dietary iron supplementation: role of NF-kappaB.

Authors:  Julie C Carrier; Elaheh Aghdassi; Khursheed Jeejeebhoy; Johane P Allard
Journal:  Int J Colorectal Dis       Date:  2005-08-23       Impact factor: 2.571

9.  Systemic iron supplementation replenishes iron stores without enhancing colon carcinogenesis in murine models of ulcerative colitis: comparison with iron-enriched diet.

Authors:  Darren N Seril; Jie Liao; Chung S Yang; Guang-Yu Yang
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

Review 10.  Anemia and inflammatory bowel diseases.

Authors:  Fernando Gomollón; Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.